Gender and responses to aspirin and clopidogrel: insights using short thrombelastography

scientific article published in January 2009

Gender and responses to aspirin and clopidogrel: insights using short thrombelastography is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1755-5922.2009.00106.X
P698PubMed publication ID19903188
P5875ResearchGate publication ID38079932

P2093author name stringNick Curzen
Zeshan Qureshi
Alex R Hobson
Phil Banks
P2860cites workIn-hospital and 1-year mortality in 1,524 women after myocardial infarction. Comparison with 4,315 men.Q45903985
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectaspirinQ18216
clopidogrelQ410237
P304page(s)246-252
P577publication date2009-01-01
P1433published inCardiovascular TherapeuticsQ1871490
P1476titleGender and responses to aspirin and clopidogrel: insights using short thrombelastography
P478volume27

Reverse relations

cites work (P2860)
Q46624023"Short" thrombelastography as a test of platelet reactivity in response to antiplatelet therapy: validation and reproducibility
Q52903388Antiplatelet effects of clopidogrel and aspirin after interventional patent foramen ovale/ atrium septum defect closure.
Q36800844Clinical characteristics associated with high on-treatment platelet reactivity of patients undergoing PCI after a 300 mg loading dose of clopidogrel, measured by thrombelastography
Q48689443Gender Differences in Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy
Q38182428Gender and anti-thrombotic therapy: from biology to clinical implications
Q35070799Influence of race and sex on thrombogenicity in a large cohort of coronary artery disease patients
Q35373683Monitoring the effectiveness of antiplatelet therapy: opportunities and limitations
Q47135592P2Y12 Receptor Antagonist, Clopidogrel, Does Not Contribute to Risk of Osteoporotic Fractures in Stroke Patients.
Q89704156Population pharmacodynamics of cilostazol in healthy Korean subjects
Q64926059Role of Gender in Dual Antiplatelet Therapy After Acute Coronary Syndrome.
Q37664571The first six-month clinical outcomes and risk factors associated with high on-treatment platelet reactivity of clopidogrel in patients undergoing coronary interventions

Search more.